Elixirgen Scientific Japan

Biotechnology Research • 村岡東２丁目２６番１号, 湘南ヘルスイノベーションパーク, Japan • 1-10 Employees

Company overview

Headquarters	村岡東２丁目２６番１号, 湘南ヘルスイノベーションパーク, 藤沢市, 神奈川 2518555, JP
Website	ricoh.com
NAICS	541714
Keywords	Cdmo, Ipsc, Neuron, Mrna
Founded	2021
Employees	1-10

Key Contact at Elixirgen Scientific Japan

Daisuke Takagi

President, Japan office

Elixirgen Scientific Japan Email Formats

Elixirgen Scientific Japan uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@elixirgensci.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@elixirgensci.com	100%

About Elixirgen Scientific Japan

Elixirgen Scientific Japan: Pioneering Regenerative Medicine and Next-Generation Drug Development Elixirgen Scientific Japan Inc. is a leading biotechnology company at the forefront of regenerative medicine and next-generation drug development, offering innovative technologies and services. iPSC Business High-quality iPSC-derived differentiated cells and differentiation induction kits. Custom differentiation contract services tailored to client needs. Assay evaluation services. mRNA CDMO Business Furthermore, Elixirgen Scientific Japan is a pioneer and leader in the mRNA Contract Development and Manufacturing Organization (CDMO) business. Leveraging our extensive experience in mRNA technology and our strengths in human pluripotent stem cell differentiation technology, we were among the first in Japan to begin mRNA manufacturing for both research and clinical trial applications. Through this business, we are at the cutting edge of a new class of pharmaceuticals – mRNA medicines – contributing to public health and well-being. Our Locations and Partnerships We are strategically located in key life science hubs within Kanagawa Prefecture. From these bases, we aim to expand our business across Japan and the Asia-Pacific region. We are also deepening our joint business development partnership with Ricoh Co., Ltd., promoting collaboration in both our iPSC and mRNA businesses. Our technological prowess and commitment to social contribution have been highly recognized, with our projects selected by institutions such as the Ministry of Economy, Trade and Industry (METI) and the Japan Agency for Medical Research and Development (AMED). Elixirgen Scientific Japan is committed to leveraging cutting-edge technology and extensive experience to unlock the future of regenerative medicine and pharmaceuticals, thereby contributing to the realization of a better society.

Elixirgen Scientific Japan revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Manager

Vice President

Employees by Department

Elixirgen Scientific Japan has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Elixirgen Scientific Japan has never raised funding before.

Frequently asked questions

Elixirgen Scientific Japan is located in 村岡東２丁目２６番１号, 湘南ヘルスイノベーションパーク, JP.

Elixirgen Scientific Japan was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Elixirgen Scientific Japan has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Elixirgen Scientific Japan

Daisuke Takagi

President, Japan office

4.8

40,000 users